Analystreport

Iterum Therapeutics PLC (NASDAQ: ITRM) had its price target lowered by analysts at SVB Leerink LLC from $2.00 to $1.00. They now have a "market perform" rating on the stock.

Iterum Therapeutics plc - Ordinary Share  (ITRM) 
Last iterum therapeutics plc - ordinary share earnings: 11/12 04:30 pm Check Earnings Report